Comparative in vitro activities of cefpiramide and apalcillin individually and in combination
- 1 May 1985
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 27 (5) , 782-790
- https://doi.org/10.1128/aac.27.5.782
Abstract
The in vitro activities of cefpiramide and apalcillin were compared with those of other third-generation cephalosporins and extended-spectrum penicillins against over 1,000 clinical bacterial isolates. The activity of cefpiramide against Pseudomonas aeruginosa was comparable to those of piperacillin and cefoperazone, inhibiting 90% of strains at concentrations less than or equal to 16.0 micrograms/ml. This drug was also active against a broad range of gram-negative organisms but was generally less active than many of the other cephalosporins tested against members of the family Enterobacteriaceae. The activity of cefpiramide against gram-positive organisms was comparable to that of cefoperazone. Apalcillin, along with ceftazidime, was the most active agent tested against P. aeruginosa and Acinetobacter calcoaceticus subsp. anitratus, inhibiting 90% of these strains at concentrations less than or equal to 8 micrograms/ml. Against other gram-negative and gram-positive organisms, its activity was similar to that of piperacillin. The activities of both cefpiramide and apalcillin were significantly reduced by the presence of several plasmid-mediated beta-lactamases in a series of otherwise isogenic strains of P. aeruginosa in comparison with their activities against a parent strain which lacks these enzymes. Many strains of Enterobacter cloacae were synergistically inhibited by the combination of gentamicin with either cefpiramide (5 of 10 strains) or apalcillin (6 of 10 strains). Most strains of P. aeruginosa were synergistically inhibited by the combination of gentamicin with either cefpiramide (8 of 10 strains) or apalcillin (10 of 10 strains). However, cefoxitin antagonized the activity of both cefpiramide and apalcillin against most of these same strains.This publication has 14 references indexed in Scilit:
- Comparative in vitro activities of apalcillin and piperacillin against gram-negative bacilliAntimicrobial Agents and Chemotherapy, 1984
- In vitro activity of apalcillin compared with those of piperacillin and carbenicillin against 6,797 bacterial isolates from four separate medical centersAntimicrobial Agents and Chemotherapy, 1984
- Pharmacokinetics of cefpiramide (SM-1652) in humansAntimicrobial Agents and Chemotherapy, 1984
- Comparative pharmacokinetics of apalcillin and piperacillinAntimicrobial Agents and Chemotherapy, 1984
- Multiply resistant viridans streptococci: susceptibility to beta-lactam antibiotics and comparison of penicillin-binding protein patternsAntimicrobial Agents and Chemotherapy, 1983
- Emergence of Resistance During Therapy with the Newer -Lactam Antibiotics: Role of Inducible -Lactamases and Implications for the FutureClinical Infectious Diseases, 1983
- Antibacterial activities of SM-1652 compared with those of other broad-spectrum cephalosporinsAntimicrobial Agents and Chemotherapy, 1982
- Resistance to Cefamandole: Derepression of -Lactamases by Cefoxitin and Mutation in Enterobacter cloacaeThe Journal of Infectious Diseases, 1982
- In vitro activity of apalcillin compared with that of other new penicillins and anti-Pseudomonas cephalosporinsAntimicrobial Agents and Chemotherapy, 1982
- PC-904, a Novel Broad-Spectrum Semisynthetic Penicillin with Marked Antipseudomonal Activity: Microbiological EvaluationAntimicrobial Agents and Chemotherapy, 1976